FISPB
RARE icon

Fideuram - Intesa Sanpaolo Private Banking’s Ultragenyx Pharmaceutical RARE Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Sell
96,480
-3,515
-4% -$87.3K 0.1% 187
2026
Q1 		$2.09M Buy
99,995
+38,666
+63% +$871K 0.07% 225
2025
Q4 		$1.41M Buy
+61,329
New +$2.02M 0.05% 257

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's RARE Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking reduced its Ultragenyx Pharmaceutical (RARE) stake by 3.5% in Q2 2026, selling an estimated $87.3K and leaving 96,480 shares worth $3.22M. The position accounts for 0.1% of the portfolio, ranked #187.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in RARE in Q4 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 96,480 shares of Ultragenyx Pharmaceutical worth $3.22M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking sold 3,515 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $87.3K.
  • Ultragenyx Pharmaceutical made up 0.1% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #187 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Ultragenyx Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.